Elevance HealthWBO:ELV +1.35%84 ROE % is 16.18% as of Mar. 2026, which is 9% above its 10-year median of 14.86. GuruFocus rates WBO:ELV with a GF Score™ of 84/100 and a GF Value™ of €442.94 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 18 Healthcare Plans companies, Elevance Health ranks better than 61.11% on this metric.
The historical rank and industry rank for Elevance Health's ROE % or its related term are showing as below:
WBO:ELV'
s ROE % Range Over the Past 10 Years
Min: 10.26 Med: 14.86 Max: 17.78
Current: 12.03
During the past 13 years, Elevance Health's highest ROE % was 17.78%. The lowest was 10.26%. And the median was 14.86%.
WBO:ELV's ROE % is ranked better than 61.11% of 18
companies
in the Healthcare Plans industry
Industry Median: 8.165
vs WBO:ELV: 12.03
Elevance Health (WBO:ELV) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Elevance Health ROE % Related Terms
Elevance Health ROE % Historical Data
* Premium members only.
The historical data trend for Elevance Health's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Healthcare Plans subindustry, Elevance Health's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elevance Health ROE % vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Elevance Health's ROE % distribution charts can be found below:
* The bar in red indicates where Elevance Health's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Elevance Health (WBO:ELV) has a ROE % of 16.18% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Elevance Health and its competitors. This is near median its historical median of 14.86. Over the past decade, Elevance Health's ROE % has ranged from 10.26 to 17.78. According to the industry distribution chart, Elevance Health ranks #7 out of 18 companies in the Healthcare Plans industry, placing it in the top 38.9%.
Is Elevance Health's ROE % too high?
Elevance Health's current ROE % of 16.18% is near median its 10-year median of 14.86. Over the past 10 years, this metric has ranged from a low of 10.26 to a high of 17.78. The Healthcare Plans industry median ROE % is 8.17. Elevance Health's value of 16.18% is 98.2% above this industry median. Based on the distribution chart, Elevance Health ranks #7 out of 18 companies in the Healthcare Plans industry, which is above the industry midpoint. Overall, Elevance Health has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elevance Health's ROE % compare to CI and CVS?
According to the Healthcare Plans industry distribution chart, Elevance Health ranks #7 out of 18 companies for ROE %. This puts Elevance Health in the upper half of its industry. The industry median ROE % is 8.17. Elevance Health's value of 16.18% is 98.2% above this benchmark. Historically, Elevance Health's own ROE % has ranged from 10.26 to 17.78 over the past decade. While the company's 10-year median is 14.86 vs. the industry median of 8.17, Elevance Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Plans company?
The median ROE % among Healthcare Plans companies is 8.17, based on 18 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Elevance Health's current ROE % of 16.18% is 98.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Elevance Health and its competitors. For the Healthcare Plans industry, the median ROE % is 8.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elevance Health's current ROE % is 16.18%, which is near median its own 10-year median of 14.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elevance Health stock overvalued right now?
Based on GuruFocus' analysis, Elevance Health (WBO:ELV) is currently considered Modestly Undervalued. The stock's GF Value™ is €442.94, compared to a current price of €344.20 — trading 22.3% below its estimated fair value. The current ROE % is 16.18%, which is near median its 10-year median of 14.86 and 98.2% above the Healthcare Plans industry median of 8.17. Elevance Health's overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Elevance Health (WBO:ELV), the current ROE % is 16.18% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Elevance Health (WBO:ELV) Overvalued in 2026?
Based on GuruFocus' analysis, Elevance Health stock appears to be undervalued.
The current stock price of €344.20 is trading 22.3% below its estimated GF Value™ of €442.94.
GuruFocus considers Elevance Health to be Modestly Undervalued.
Key valuation signals for WBO:ELV:
ROE %: 16.18% (near median its 10-year median of 14.86)
GF Value™: €442.94 vs. price of €344.20 (22.3% below fair value)
Industry Position: 98.2% above the Healthcare Plans median (#7 of 18)
No single metric tells the full story. See the WBO:ELV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
84GF Score
Get the complete analysis for WBO:ELV
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:ELV has been successfully added to your 
